Country: United States
Language: English
Source: NLM (National Library of Medicine)
potassium chloride (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152)
Laboratoire Aguettant
INTRAVENOUS
PRESCRIPTION DRUG
Unapproved drug for use in drug shortage
CHLORURE DE POTASSIUM PROAMP- POTASSIUM CHLORIDE INJECTION, SOLUTION, CONCENTRATE LABORATOIRE AGUETTANT _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP LA JOLLA Pharmaceutical AGUETTANT ESSENTIAL MEDICINES IMPORTANT PRESCRIBING INFORMATION SUBJECT: TEMPORARY IMPORTATION OF POTASSIUM CHLORIDE PROAMP® 0.15 G/ML (EQUIVALENT TO 2 MEQ/ML), CONCENTRATE FOR SOLUTION FOR INFUSION TO ADDRESS DRUG SHORTAGE June, 2018 Dear Healthcare Professional, Due to the critical shortage of Potassium Chloride for Injection Concentrate 2 mEq/mL, USP in the United States (U.S.) market, Laboratoire Aguettant (Aguettant) is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of Potassium Chloride for Injection. Aguettant has initiated temporary importation of its Potassium Chloride Proamp® 0.15 g/mL (equivalent to 2 mEq/mL) concentrate for solution for infusion. This product is manufactured and marketed in France by Aguettant. Given the scale of this shortage, FDA is coordinating with several firms to import Potassium Chloride for Injection 2 mEq/mL. At this time, however, no other entity except La Jolla Pharmaceutical Company is authorized by the FDA to import or distribute Aguettant's Potassium Chloride Proamp® 0.15 g/mL (equivalent to 2 mEq/mL) concentrate for solution for infusion. FDA has not approved Aguettant's Potassium Chloride Proamp® 0.15 g/mL concentrate for solution for infusion, but allows its temporary importation into the United States. You may be provided with additional letters for other imported products you receive. Please read each letter in its entirety because each letter may contain different, product-specific information. Effective immediately, and during this temporary period, Aguettant will offer the following presentation of Potassium Chloride for Injection: PRODUCT NAME AND Read the complete document